{
    "organizations": [],
    "uuid": "48d27015aa5501a24c795b2c3a5358367fd16bf6",
    "author": "Jonathan D. Rockoff",
    "url": "https://www.wsj.com/articles/epipen-emergency-allergy-shot-in-short-supply-fda-says-1525878453",
    "ord_in_thread": 0,
    "title": "EpiPen Emergency Allergy Shot in Short Supply, FDA Says",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "The EpiPen emergency treatment for allergic reactions is in short supply in the U.S. because of manufacturing delays, the Food and Drug Administration said Wednesday.\nMylan NV, which sells EpiPens that are manufactured at a Pfizer Inc. plant, said some pharmacies lacked supply, but that patients could find the drug at other pharmacies. Pfizer said it was overcoming the manufacturing problems, saying it was increasing production.\n... ",
    "published": "2018-05-09T19:55:00.000+03:00",
    "crawled": "2018-05-10T02:19:08.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "epipen",
        "emergency",
        "treatment",
        "allergic",
        "reaction",
        "short",
        "supply",
        "manufacturing",
        "delay",
        "food",
        "drug",
        "administration",
        "said",
        "wednesday",
        "mylan",
        "nv",
        "sell",
        "epipens",
        "manufactured",
        "pfizer",
        "plant",
        "said",
        "pharmacy",
        "lacked",
        "supply",
        "patient",
        "could",
        "find",
        "drug",
        "pharmacy",
        "pfizer",
        "said",
        "overcoming",
        "manufacturing",
        "problem",
        "saying",
        "increasing",
        "production"
    ]
}